IOL Chemicals and Pharmaceuticals Limited, a leading producer of both pharmaceuticals and specialty chemicals, has appointed Vikas Vij as its new Chief Executive Officer. This appointment, effective April 3, 2023, is set to take the company to new heights in India and abroad. With over 30 years of experience in the pharma industry, including top leadership roles at companies such as Cipla, Ranbaxy, and Alembic Pharmaceuticals, Vij brings a wealth of industry knowledge and expertise to the role.
Vij, who takes the helm from Dr. Sanjay Chaturvedi, said, “I’m eager to work with the talented team at IOL and help drive the company’s next phase of growth. It’s a true honor to lead a company that is making such a positive impact on people’s lives and on the Indian Pharmaceutical Industry.”
IOL Chemicals and Pharmaceuticals is a leader in the specialty chemicals space, with a product portfolio that includes APIs like Ibuprofen and specialty chemicals like Ethyl Acetate. The company is committed to sustainability and operates with a state-of-the-art Effluent Treatment Plant and a 17 MW captive Co-Generation plant, demonstrating its dedication to responsible operations. With a strong presence across major therapeutic categories and a world-class facility, IOL Chemicals and Pharmaceuticals is poised for continued success, both in India and in other markets.
Joint Managing Director of IOL Chemicals and Pharmaceuticals, Vikas Gupta, said, “We’re thrilled to welcome Vikas Vij as CEO of IOL Chemicals and Pharmaceuticals. He’s a seasoned leader with a proven track record of driving growth and success in the pharmaceutical and specialty chemicals industries. With his exceptional skills and experience, we’re confident that he will lead IOL to new levels of success, both in India and in other markets.”
Author
